Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients-Reference-Cited by-同舟云学术

Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients

Published:2022-04-12 Issue:7 Volume:52 Page:586-596
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Umemura Machiko¹,Ogawa Koji¹^ORCID,Morikawa Kenichi¹^ORCID,Kubo Akinori¹,Tokuchi Yoshimasa¹,Yamada Ren¹,Kitagataya Takashi¹,Shigesawa Taku¹,Shimazaki Tomoe¹,Kimura Megumi¹,Suzuki Kazuharu¹,Nakamura Akihisa¹,Ohara Masatsugu¹,Kawagishi Naoki¹^ORCID,Izumi Takaaki¹,Nakai Masato¹,Sho Takuya¹,Suda Goki¹^ORCID,Natsuizaka Mitsuteru¹,Ono Kota²,Murata Kazumoto³^ORCID,Sugiyama Masaya⁴,Mizokami Masashi⁴,Sakamoto Naoya¹

Affiliation:

1. Department of Gastroenterology and Hepatology Hokkaido University Faculty of Medicine and Graduate School of Medicine Sapporo Japan

2. Clinical Research and Medical Innovation Center Hokkaido University Hospital Sapporo Japan

3. Division of Virology Department of Infection and Immunity Jichi Medical University Shimotsuke Japan

4. The Research Center for Hepatitis and Immunology National Center for Global Health and Medicine Ichikawa Japan

Funder

JSPS KAKENHI

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13768

Reference43 articles.

1. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

2. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years

3. Hepatitis B virus infection

4. JSH Guidelines for the Management of Hepatitis B Virus Infection

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D;Liver International;2023-10-03

2. Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-11-23

3. Risk of HCC in Patients with HBV, Role of Antiviral Treatment;Current Hepatology Reports;2022-09-05